Views & Analysis 5 questions: making Multiple Sclerosis care more patient-cen... Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.
News Teva appoints Lundbeck's Kare Schultz as CEO Unlike AZ's Soriot, Schultz "couldn't refuse" top job at Teva.
Views & Analysis The best of digital pharma: MS Explorer Understanding Multiple Sclerosis using cutting-edge 3D projection technology.
News Novartis launches first smartphone-enabled study in MS Novartis has launched a research study for people with multiple sclerosis (MS) that collects data via their smartphone.
Views & Analysis Addressing the growing need for better Multiple Sclerosis ca... Jo Sopala of the MS Trust describes the organisation's work in creating better multiple sclerosis care.
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
